Pan-cancer analysis reveals differential PERK expression across tumour types and its potential as a therapeutic target.
Saved in:
| Title: | Pan-cancer analysis reveals differential PERK expression across tumour types and its potential as a therapeutic target. |
|---|---|
| Authors: | Kumar S; School of Medicine, Pharmacy and Biomedical Sciences, Faculty of Science and Health, University of Portsmouth, Portsmouth, PO1 2DT, UK., Han N; Cambridge Centre for AI in Medicine, University of Cambridge, Cambridge, CB2 0QQ, UK.; Milner Therapeutics Institute, University of Cambridge, Cambridge, CB4 0WS, UK., Tsagkogeorga G; Milner Therapeutics Institute, University of Cambridge, Cambridge, CB4 0WS, UK.; STORM Therapeutics Ltd, Babraham Research Campus, Cambridge, CB22 3AT, UK., Wan MLY; School of Medicine, Pharmacy and Biomedical Sciences, Faculty of Science and Health, University of Portsmouth, Portsmouth, PO1 2DT, UK. murphy.wan@med.lu.se.; Department of Laboratory Medicine, Division of Microbiology, Immunology and Glycobiology, Lund University, Lund, 221 84, Sweden. murphy.wan@med.lu.se. |
| Source: | Discover oncology [Discov Oncol] 2026 Mar 25; Vol. 17 (1). Date of Electronic Publication: 2026 Mar 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
